Target intelligence / Profile preview

Intestinal epithelial tight and adherens junction proteins (AJC)

Target
AJC
Molecular classification
Cell adhesion molecule, Scaffolding protein, Transmembrane protein, Other
01

Overview

The intestinal epithelial tight and adherens junction proteins constitute the apical junctional complex (AJC), which serves as the primary physical barrier between the intestinal lumen and the underlying mucosal immune system. Tight junctions, including claudins, occludin, and zonula occludens proteins, regulate paracellular permeability and maintain cell polarity, while adherens junctions, featuring E-cadherin and catenins, provide the adhesive strength necessary for tissue integrity (PMID: 23303615, 28461160). Disruption of these junctional complexes is a central feature in the pathogenesis of inflammatory bowel disease (IBD), celiac disease, and irritable bowel syndrome, where 'leaky gut' allows for the translocation of luminal antigens that trigger chronic inflammation (PMID: 22314561). Pharmacological modulation of these proteins, such as through zonulin antagonists like larazotide acetate or growth factors like glucagon-like peptide-2 (GLP-2) analogs, aims to seal the barrier and reduce systemic inflammatory triggers. Consequently, these proteins are high-priority targets for drug development in gastroenterology and autoimmune research.

Other names
Apical junctional complexIntestinal barrier proteinsTight junction proteinsAdherens junction proteinsParacellular junctional complex
02

Mechanism of action

Modulation of paracellular permeability through the regulation of tight junction assembly, antagonism of zonulin-mediated disassembly, and enhancement of junctional protein expression and localization.

03

Biological functions

Cell-cell adhesionParacellular permeability regulationCell polaritySignal transductionImmune response
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseIrritable bowel syndromeInfectionCancerOther
05

Safety considerations

Risk of systemic absorption of luminal antigensPotential for unintended effects on other epithelial barriersRisk of promoting epithelial-mesenchymal transition in cancer contexts
06

Interacting drugs

Larazotide acetate

6 more in the full profile.

07

Biomarkers

Serum zonulinLactulose/mannitol ratioClaudin-3Occludin expressionTransepithelial electrical resistance (TEER)

Beyond the preview

Go deeper on Intestinal epithelial tight and adherens junction proteins (AJC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial tight and adherens junction proteins (AJC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call